Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline.
Publication
, Journal Article
O'Shea, JC; Lorenz, TJ; Joseph, D; Kitt, MM; Greenberg, S; Lui, H; Cantor, W; Cohen, E; Tcheng, JE
Published in: AMERICAN JOURNAL OF CARDIOLOGY
October 16, 2000
Duke Scholars
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
October 16, 2000
Volume
86
Issue
8A
Start / End Page
13I / 14I
Publisher
EXCERPTA MEDICA INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Shea, J. C., Lorenz, T. J., Joseph, D., Kitt, M. M., Greenberg, S., Lui, H., … Tcheng, J. E. (2000). Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline. AMERICAN JOURNAL OF CARDIOLOGY, 86(8A), 13I-14I.
O’Shea, J. C., T. J. Lorenz, D. Joseph, M. M. Kitt, S. Greenberg, H. Lui, W. Cantor, E. Cohen, and J. E. Tcheng. “Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline.” AMERICAN JOURNAL OF CARDIOLOGY 86, no. 8A (October 16, 2000): 13I-14I.
O’Shea JC, Lorenz TJ, Joseph D, Kitt MM, Greenberg S, Lui H, et al. Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline. AMERICAN JOURNAL OF CARDIOLOGY. 2000 Oct 16;86(8A):13I-14I.
O’Shea, J. C., et al. “Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 86, no. 8A, EXCERPTA MEDICA INC, Oct. 2000, pp. 13I-14I.
O’Shea JC, Lorenz TJ, Joseph D, Kitt MM, Greenberg S, Lui H, Cantor W, Cohen E, Tcheng JE. Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2000 Oct 16;86(8A):13I-14I.
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
October 16, 2000
Volume
86
Issue
8A
Start / End Page
13I / 14I
Publisher
EXCERPTA MEDICA INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology